Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Graft versus host disease in unmanipulated haploidentical marrow transplantation with a modified post-transplant cyclophosphamide (PT-CY) regimen: an update on 425 patients
Authors
Keywords
-
Journal
BONE MARROW TRANSPLANTATION
Volume 54, Issue S2, Pages 708-712
Publisher
Springer Science and Business Media LLC
Online
2019-08-21
DOI
10.1038/s41409-019-0594-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Haploidentical Bone Marrow Transplantation with Post-Transplant Cyclophosphamide/Bendamustine in Pediatric and Young Adult Patients with Hematologic Malignancies
- (2018) Emmanuel Katsanis et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- A Modified Post-Transplant Cyclophosphamide Regimen, for Unmanipulated Haploidentical Marrow Transplantation, in Acute Myeloid Leukemia: A Multicenter Study
- (2018) Patrizia Chiusolo et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Teaching a Young Dog New Tricks: Modifications to the Post-Transplantation Cyclophosphamide Haploidentical Transplantation Platform
- (2018) Christopher G. Kanakry et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Myeloablative and reduced-intensity conditioning in HLA-haploidentical peripheral blood stem cell transplantation using post-transplant cyclophosphamide
- (2018) Junichi Sugita et al. BONE MARROW TRANSPLANTATION
- Mobilized Peripheral Blood Stem Cells Versus Unstimulated Bone Marrow As a Graft Source for T-Cell–Replete Haploidentical Donor Transplantation Using Post-Transplant Cyclophosphamide
- (2017) Asad Bashey et al. JOURNAL OF CLINICAL ONCOLOGY
- Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant
- (2016) Annalisa Ruggeri et al. HAEMATOLOGICA
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft- versus -host disease prophylaxis in haploidentical transplant
- (2016) Annalisa Ruggeri et al. HAEMATOLOGICA
- Comparable composite endpoints after HLA-matched and HLA-haploidentical transplantation with post-transplantation cyclophosphamide
- (2016) Shannon R. McCurdy et al. HAEMATOLOGICA
- Haploidentical transplant with posttransplant cyclophosphamide vs matched unrelated donor transplant for acute myeloid leukemia
- (2015) S. O. Ciurea et al. BLOOD
- T-replete haploidentical allogeneic transplantation using post-transplantation cyclophosphamide in advanced AML and myelodysplastic syndromes
- (2015) R Devillier et al. BONE MARROW TRANSPLANTATION
- Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease
- (2015) J. Palmer et al. HAEMATOLOGICA
- Failure-free survival in a prospective cohort of patients with chronic graft-versus-host disease
- (2015) J. Palmer et al. HAEMATOLOGICA
- Unmanipulated Haploidentical Bone Marrow Transplantation and Posttransplantation Cyclophosphamide for Hematologic Malignancies after Myeloablative Conditioning
- (2012) Anna Maria Raiola et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Reduced-intensity conditioning using fludarabine, melphalan and thiotepa for adult patients undergoing haploidentical SCT
- (2009) S O Ciurea et al. BONE MARROW TRANSPLANTATION
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search